This paper is in the following e-collection/theme issue:

mHealth for Data Collection and Research (1196) Use and User Demographics of mHealth (402) mHealth for Symptom and Disease Monitoring, Chronic Disease Management (1732)

Published on in Vol 10, No 8 (2022): August

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/38331, first published .
Quality of Life and Physical Activity in 629 Individuals With Sarcoidosis: Prospective, Cross-sectional Study Using Smartphones (Sarcoidosis App)

Quality of Life and Physical Activity in 629 Individuals With Sarcoidosis: Prospective, Cross-sectional Study Using Smartphones (Sarcoidosis App)

Quality of Life and Physical Activity in 629 Individuals With Sarcoidosis: Prospective, Cross-sectional Study Using Smartphones (Sarcoidosis App)

Authors of this article:

Brian Chu1 Author Orcid Image ;   Daniel M O'Connor2 Author Orcid Image ;   Marilyn Wan1 Author Orcid Image ;   Ian Barnett3 Author Orcid Image ;   Haochang Shou3 Author Orcid Image ;   Marc Judson4 Author Orcid Image ;   Misha Rosenbach1 Author Orcid Image
Article Authors Cited by (9) Tweetations (12) Metrics

Journals

  1. Christon L, Chandler J, Benfield K, Pairet S, Hoffman M, Treiber F, James W. Perceptions of the fatigue experience and a breathing awareness meditation-integrated mHealth App for fatigue and stress in patients with sarcoidosis. Fatigue: Biomedicine, Health & Behavior 2023;11(1):14 View
  2. Iwakura M, Kawagoshi A, Tamaki A, Oki Y, Oshima Y, Spruit M. Physical activity measurements in individuals with interstitial lung disease: a systematic review and meta-analysis. European Respiratory Review 2023;32(169):220165 View
  3. Poleur M, Markati T, Servais L. The use of digital outcome measures in clinical trials in rare neurological diseases: a systematic literature review. Orphanet Journal of Rare Diseases 2023;18(1) View
  4. Judson M. The Symptoms of Pulmonary Sarcoidosis. Journal of Clinical Medicine 2023;12(18):6088 View
  5. Vizel A, Avdeev S, Vizel I, Shakirova G, Vlasenko A. Course of sarcoidosis in patients treated with systemic corticosteroids. PULMONOLOGIYA 2023;33(5):634 View
  6. Judson M. Health-Related Quality of Life Assessment in Sarcoidosis. Clinics in Chest Medicine 2024;45(1):159 View
  7. Fadaizadeh L, Velayati F, Shojaee-Mend H. Telehealth in sarcoidosis: a scoping review. BMC Pulmonary Medicine 2025;25(1) View
  8. Tana C, Drent M, Obi O, Cinetto F, Bernardinello N, Moffa L, Tana M, Israël Biet D, Spagnolo P. Multidisciplinary strategies and new technologies in the management of sarcoidosis. European Journal of Internal Medicine 2025:106576 View
  9. Wells A, Lower E, Baughman R, Culver D, Judson M, Bonham C, Gerke A, Grutters J, Knoet C, Martone F, Schillhorn K, Stone J, Wilson A, Crouser E. A paradigm shift in corticosteroid therapy for sarcoidosis: a World Association of Sarcoidosis and Other Granulomatous Disorders Position Paper, endorsed by the Americas Association of Sarcoidosis and Other Granulomatous Disorders. The Lancet Respiratory Medicine 2025 View